MedTrace Logo

Allergy Skin Patch Artificial Intelligence (AI)

NCT05339750 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 233

Last updated 2023-01-06

No results posted yet for this study

Summary

The purpose of this research is to assess human and artificial intelligence performance in grading contact dermatitis reactions in healthy volunteers.

Conditions

  • Allergic Contact Dermatitis

Interventions

DEVICE

AI-based smartphone application

AI-based smartphone application to record and interpret the patch test results

DIAGNOSTIC_TEST

Allergen patch

Allergens applied to a patch which is placed on the skin on the forearm region. The patch contains 10 dime-sized disks which contain a different allergen.

Sponsors & Collaborators

Principal Investigators

  • Matthew Hall, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-15
Primary Completion
2022-09-23
Completion
2022-09-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05339750 on ClinicalTrials.gov